Rhabdomyolysis Induced by the Interaction Between Ribociclib and Statins- Case Report and Literature Review

Cyclin-dependent kinase (CDK) 4/6 inhibitors given with endocrine therapy are standard of care for the treatment of women with advanced hormone receptor (HR) positive and human epidermal growth factor receptor 2 (HER-2) negative breast cancer. Ribociclib is a CDK 4/6 inhibitor with moderate to solid...

Descripción completa

Detalles Bibliográficos
Autores principales: Badran, Omar, Abu Amna, Mahmoud, Turgeman, Ilit, Bar-Sela, Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883986/
https://www.ncbi.nlm.nih.gov/pubmed/36718280
http://dx.doi.org/10.2147/BCTT.S380485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883986/
https://www.ncbi.nlm.nih.gov/pubmed/36718280
http://dx.doi.org/10.2147/BCTT.S380485

Ejemplares similares